A novel EyePhone© App for improving adherence to glaucoma therapy

Leshno, Ari; Gaton, Dan D.; Singer, Reut; Eliasi, Elior; Vorobichik-Berar, Ofri; Madgar, Shiran; Stern, Ori; Jaber, Wasim; Kapelushnik, Noa; Skaat, Alon

doi:10.1007/s00417-021-05091-6

Cited by 10 publications

(3 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The “EYE is OK” app is the first smartphone app with interactive online management for myopia control. Although many of the small-scale studies published thus far provide promising evidence supporting the potential of mobile apps to positively impact adherence and treatment outcomes among children and young people [ 20 ], most existing ophthalmology-related apps are limited to diagnosis, screening [ 24 ] or reminding [ 33 ], and data collection for dry eye [ 34 ]. Our app includes functions such as recording, reminding, and education, and it requires trained ECPs to review the patient’s compliance behavior before a follow-up, record the axial length during the current visit as well as the date for the next visit, and provide the patient with tailored health education information, thereby improving the patient’s compliance behavior, reducing the risk of comorbidities, and minimizing axial length growth.…”

Section: Discussionmentioning

confidence: 99%

A Cooperative Management App for Parents with Myopic Children Wearing Orthokeratology Lenses: Mixed Methods Pilot Study

Sun

Liao

et al. 2021

IJERPH

View full text Add to dashboard Cite

Orthokeratology (OK) lens wear is an effective modality to inhibit axial elongation in myopic children. Willingness for commitment from both parents and children contributes to the success of OK treatment. We aimed to develop and assess the usability of a mobile application on OK lens wear by quantitatively and qualitatively evaluating parents with myopic children and eye care professionals (ECPs). Moreover, the preliminary outcome was also evaluated in this study. The app was developed and tested using a co-design approach involving key stakeholders. Two prototype tests were conducted during the feasibility and utility assessment. The app features include self-reported compliance documentation, analytics, and personalized and generalized messages for compliance behaviors of OK lenses. After the trial period, the full usage of app functions ranged from 40% to 60% among the enrolled parents. After app implementation, the compliance with follow-up visits substantially improved. Qualitative data show that the high-satisfaction app functions reported by parents were the app’s reminder and axial length recording, although it was recommended that the number of compliance questions should be reduced to minimize the survey completion time. Additionally, who should complete the recording of the axial length data as well as the management and reminder for the follow-up visit remained controversial. This is the first app developed to improve parents of myopic children’s compliance with OK lens wear and to assist ECPs and parents in collaboratively monitoring and managing the use and care of OK lenses among myopic children. This study highlights the importance of interdisciplinary collaboration in the design, development, and validation of such an app.

show abstract

Section: Discussionmentioning

confidence: 99%

A Cooperative Management App for Parents with Myopic Children Wearing Orthokeratology Lenses: Mixed Methods Pilot Study

Sun

Liao

et al. 2021

IJERPH

View full text Add to dashboard Cite

show abstract

“…The ubiquity of mobile devices offers an opportunity for convenient automated direct-to-patient communication, and 72% of glaucoma patients expressed interest in downloading a reminder application to their smartphones [125]. Daily voice and/or text message reminders, or the use of a reminder application, significantly improves adherence [126,127 ▪ ].…”

Section: Approaches To Improve Adherencementioning

confidence: 99%

Identifying and addressing common contributors to nonadherence with ophthalmic medical therapy

Hovanesian

Singh²,

Bauskar³

et al. 2023

Current Opinion in Ophthalmology

View full text Add to dashboard Cite

Purpose of reviewTo discuss common reasons for nonadherence and review existing and emerging options to reduce nonadherence with ocular medical therapy and optimize therapeutic outcomes.Recent findingsNonadherence can arise from patient-related issues (e.g. physical, cognitive) and healthcare-related issues (e.g. cost, access to care). Multiple strategies have been developed and evaluated to overcome these barriers to adherence. Identifying nonadherence and its cause(s) facilitates the development of strategies to overcome it.SummaryMany common causes of nonadherence can be mitigated through a variety of strategies presented.

show abstract

“…This implies that while some interventions do appear to impact adherence, their effect on disease progression has not been consistently shown. For instance, Leshno et al [17] reported improved adherence and IOP after use of their intervention involving the "EyePhone" App, a smartphone reminder system. At the same time, Dreer et al [18] did not find an improvement in IOP despite their multifaceted intervention that also improved adherence.…”

Section: Introductionmentioning

confidence: 99%

How Medication Adherence Affects Disease Management in Veterans with Glaucoma: Lessons Learned from a Clinical Trial

et al. 2023

View full text Add to dashboard Cite

Introduction: We conducted a secondary, real-world clinical assessment of a randomized controlled trial to determine how a glaucoma medication adherence intervention impacted the clinical outcomes of participants at 12 months post randomization. Participants included veterans at a VA eye clinic with medically treated glaucoma who reported poor adherence, and their companions if applicable. Methods: The treatment group received a glaucoma education session with drop administration instruction, and virtual reminders from a “smart bottle” (AdhereTech) for their eye drops. The control group received a general eye health class, and the smart bottle with the reminder function turned off. Medical chart extraction determined if participants in each group experienced visual field progression, additional glaucoma medications, or a recommendation for surgery or laser due to inadequate intraocular pressure (IOP) control over the 12 months following randomization. The main outcome measure was disease progression, defined as visual field progression or escalation of glaucoma therapy, in the 12 months following randomization. Results: Thirty-six vs. 32% of the intervention (n=100) vs. control (n=100) group, respectively experienced disease intensification. There was no difference between the intervention and control groups in terms of intensification, [Intervention vs. Control Group Odds Ratio: 1.20, 95% Confidence Interval: (0.67, 2.15)], including when age, race, and disease severity were accounted for in the logistic regression model. Those whose study dates included time during the COVID-19 pandemic were evenly distributed between groups. Conclusions: A multi-faceted intervention that improved medication adherence for glaucoma for 6 months did not affect the clinical outcomes measured at 12 months post randomization. Twelve months may not be long enough to see the clinical effect of this intervention or more than 6 months of intervention are needed.

show abstract

A novel EyePhone© App for improving adherence to glaucoma therapy

Cited by 10 publications

References 43 publications

A Cooperative Management App for Parents with Myopic Children Wearing Orthokeratology Lenses: Mixed Methods Pilot Study

A Cooperative Management App for Parents with Myopic Children Wearing Orthokeratology Lenses: Mixed Methods Pilot Study

Identifying and addressing common contributors to nonadherence with ophthalmic medical therapy

How Medication Adherence Affects Disease Management in Veterans with Glaucoma: Lessons Learned from a Clinical Trial

Contact Info

Product

Resources

About